U.S. Markets closed

The Top Cancer Immunotherapies Expected to Reach $1 Billion in Sales in 2017

newsfeedback@fool.com (Sean Williams)
The Top Cancer Immunotherapies Expected to Reach $1 Billion in Sales in 2017

These next-generation medicines are quickly becoming the foundation for advanced cancer treatments.